The patients who undergo percutaneous transhepatic biliary drainage (PTBD) or endoscopic nasobiliary drainage (ENBD) due to biliary obstruction. Among the, patients who were included the study "
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients who undergo transhepatic biliary drainage (PTBD) or endoscopic nasobiliary drainage (ENBD) due to obstructive jaundice. 2. Patients who agree to participate this study. Note; patients who are undergoing antibiotics therapy such as Chloramphenicol will not be excluded.
Exclusion criteria
Exclusion criteria: 1. Patients who do not agree to participate this study. 2. Patients who are not eligible to participate this study (determined by chief or associate doctors who are responsible to perform this study. 3. Patients who are allergic to Inchinkoto. 4. Patients who are taking choleretic drugs such as ulsodeoxycholic acid.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Alternation of metabolome after an oral intake of Inchinkoto. | — |
Secondary
| Measure | Time frame |
|---|---|
| The association between the serum concentrations of genipin, geniposide, and 6,7-dimetylesculetin and the biliary concentrations of total bilirubin, direct bilirubin, and bile acid. | — |
Countries
Japan
Contacts
Nagoya University Hospital Surgery 1